U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219420) titled 'A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis' on Oct. 17.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of bimekizumab compared with placebo in participants with palmoplantar pustulosis (PPP).
Study Start Date: Nov. 03
Study Type: INTERVENTIONAL
Condition:
Palmoplantar Pustulosis
Intervention:
DRUG: Bimekizumab
Study participants will receive bimekizumab at pre-specified time points.
DRUG: Placebo
Study participants will receive matching placebo at pre-specified time points.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: UC...